(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VABOMERE MEROPENEM AND VABORBACTAM FOR INJECTION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VABOMERE MEROPENEM AND VABORBACTAM FOR INJECTION

ST13

US500000087668224

Class

5

Filing

87668224

Registration

5681621

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

09/25/2025

Trademark type

Combined

Nice classes

5

Filing date

11/01/2017

Registration date

02/19/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/03/2025

Last transaction

09/25/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/23/2017

First use in commerce

10/23/2017

Drawing code

3

Owner type

16

Owner location

Parsippany, NJ

Examiner

LEE, JANET

Current location

Historical data usage

Mark description

The mark consists of the wording "VABOMERE" over the wording "MEROPENEM AND VABORBACTAM", which is over the wording "FOR INJECTION". A design of an open arrow is to the left of the wording "VABOMERE".

Holders and representatives

Holders

MELINTA THERAPEUTICS, LLC
MELINTA THERAPEUTICS, INC.
The Medicines Company

Representatives

Jorge Arciniega Loeb & Loeb LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsanti-infective preparations and substances for medical purposes; Pharmaceutical preparationsanti-infection preparationsantimicrobial preparations for treating bacterial infectionsantifungal preparations

Publications

History of USPTO decisions and trademark events.

43 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/24/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/03/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/03/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/03/2025

E815

TEAS SECTION 8 & 15 RECEIVED

09/17/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/19/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/26/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/28/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/13/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/29/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/29/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/29/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/29/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/29/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

02/19/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/16/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/15/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/09/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/09/2019

IUAF

USE AMENDMENT FILED

12/05/2018

EISU

TEAS STATEMENT OF USE RECEIVED

12/05/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/04/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/09/2018

PUBO

PUBLISHED FOR OPPOSITION

10/09/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/19/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/05/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/31/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2018

ALIE

ASSIGNED TO LIE

08/29/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/22/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/13/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/10/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/10/2018

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

02/13/2018

GPRA

PRIORITY ACTION E-MAILED

02/13/2018

CPRA

PRIORITY ACTION WRITTEN

02/13/2018

DOCK

ASSIGNED TO EXAMINER

02/12/2018

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/10/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/09/2017

NWAP

NEW APPLICATION ENTERED

11/04/2017

Continuous trademark protection

Get notified about every new filing that threatens VABOMERE MEROPENEM AND VABORBACTAM FOR INJECTION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.